Bioventus Inc (BVS)

Healthcare Medical Devices

13.20 $

-0.1% vs. previous close

Closing price · As of: 31. Jul 2026

Add to watchlist

Stock Watch

Stock Watch will tell you what changes at Bioventus Inc.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Appears in These Scanners

This stock currently matches 8 of our scanner strategies — each hit links to the scanner.

Quality & Balance Sheet

Institutional Accumulation Pros 80%

Breakout & Setup

Strong DCR (≥80) Tight Weekly Range (WCR≥90)

Momentum & Trend

21-EMA Trend Above the 50- & 200-SMA Power Trend Stan Weinstein: Stage 2

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners

Basics

Market Cap

0.9$B

Shares Outstanding

68Mio.

Float

49.2%

Beta

0.7

Performance

Perf. 1M

10.30%

Perf. 3M

9.40%

Perf. 6M

32.50%

YTD Performance (%)

24.90%

52-Week-High Distance

-13.5%

Perf. 1Y

45.71%

Perf. 3Y

210.70%

Perf. 5Y

-47.37%

Valuation

P/E

31.9

Forward P/E

13.5

PEG

1.4

P/B

4.6

P/S

1.5

EV/EBITDA

9.2

Price/FCF

8.6

Profitability

Gross Margin

68.7%

EBIT Margin

–

Net Margin

4.9%

Return on Equity

16.5%

Return on Assets

5.6%

Balance Sheet & Safety

Equity Ratio

–

Debt/Equity

1.4

Altman Z″

3.68

very solid

Piotroski

8 out of 9

Growth

Sales Growth Last Quarter

6.60%

EPS Growth Last Quarter

0.00%

Sales Growth (Year)

-0.91%

Forward Sales Growth

6.63%

Forward EPS Growth

16.80%

Dividend

This stock currently pays no dividend.

Quality & Screener

Stage

RS Rating

EPS Rating

very solid

Piotroski

8 out of 9

Fundamental Rating

B (57 out of 100)

Altman Z″

3.68

AI Rating

–

Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Analysts & Price Target

Current Price 13.20 $

Price Target (average) 14.80 $

The price target sits 12.1% above the current price.

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Next Reporting Date

5. Aug 2026 · before the open · Q2 2026

Expected Earnings per Share: 0.22 $

Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.

From To Indexed

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)

Source: fundamental data

Compare with other stocks →

Quarterly Figures

Quarterly Figures
Quarter	EPS (Earnings Per Share)	EPS YoY (%)	Sales ($M)	Sales YoY (%)	Net Margin (%)	OCF ($M)	FCF ($M)
2024: Q4	0.00	–	154	13.50	-0.10	19	19
2025: Q1	-0.04	–	124	-4.30	-2.10	-19	-20
2025: Q2	0.11	–	148	-2.40	5.10	26	25
2025: Q3	0.05	–	139	-0.20	2.30	30	30
2025: Q4	0.21	–	158	2.80	9.30	38	37
2026: Q1	0.04	–	132	6.60	2.40	9	8

What Do These Terms Mean?

EPS (Earnings Per Share):: Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):: Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:: All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:: What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):: The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):: Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

About the Company

Bioventus Inc., ein Medizinprodukteunternehmen, konzentriert sich auf Schmerzlinderung und muskuloskelettale Therapien in den USA und international.

Employees	940
Headquarters	Durham, NC
Website	bioventus.com
IPO Date	11. Feb 2021

Management

Management
Name	Title	Birth Year
Robert E. Claypoole	President, CEO & Director	1972
Mark L. Singleton	Senior VP & CFO	1969
Anthony D'Adamio J.D.	Senior VP, General Counsel & Corporate Secretary	1961
Mike Crowe B.S., M.B.A.	Senior Vice President of Operations	–
David Crawford	Vice President of Investor Relations & Treasurer	–
Katrina J. Church J.D.	Senior VP & Chief Compliance Officer	1962
Helen Leupold	Senior VP & Chief Human Resources Officer	–
Dave Venner	Senior VP & GM of Surgical	–

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Chart

Interactive price chart (TradingView).

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.